Ident. | Authors (with country if any) | Title |
---|
000038 |
D. M. Johnstone [Australie] ; N. El Massri [Australie] ; C. Moro [France] ; S. Spana [Australie] ; X. S. Wang [Australie] ; N. Torres [France] ; C. Chabrol [France] ; X. De Jaeger [France] ; F. Reinhart [France] ; S. Purushothuman [Australie] ; A.-L. Benabid [France] ; J. Stone [Australie] ; J. Mitrofanis [Australie] | INDIRECT APPLICATION OF NEAR INFRARED LIGHT INDUCES NEUROPROTECTION IN A MOUSE MODEL OF PARKINSONISM - AN ABSCOPAL NEUROPROTECTIVE EFFECT |
000173 |
WEI SONG [Canada] ; Hillel Zukor [Canada] ; Shih-Hsiung Lin [Canada] ; Adrienne Liberman [Canada] ; Ayda Tavitian [Canada] ; Jeannie Mui [Canada] ; Hojatollah Vali [Canada] ; Carine Fillebeen [Canada] ; Kostas Pantopoulos [Canada] ; Ting-Di Wu [France] ; Jean-Luc Guerquin-Kern [France] ; Hyman M. Schipper [Canada] | Unregulated brain iron deposition in transgenic mice over-expressing HMOX1 in the astrocytic compartment |
000232 |
Sophie Schumm [France] ; Claude Sebban [France] ; Charles Cohen-Salmon [France] ; Jacques Callebert [France] ; Jean-Marie Launay [France] ; Jean-Louis Golmard [France] ; Lydie Boussicault [France] ; Isabelle Petropoulos [France] ; Audrey Hild [France] ; Estelle Rousselet [France] ; Annick Prigent [France] ; Bertrand Friguet [France] ; Jean Mariani [France] ; Etienne C. Hirsch [France] | Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine |
000311 |
Elaine Del-Bel [France] ; Fernando Eduardo Padovan-Neto [France] ; Rita Raisman-Vozarl [France] ; Marcio Lazzarini [France] | Role of Nitric Oxide in Motor Control: Implications for Parkinson's Disease Pathophysiology and Treatment |
000323 |
Benjamin Dehay [France] ; Erwan Bezard [France] | New Animal Models of Parkinson's Disease |
000346 |
Giselle Charron [France] ; Evelyne Doudnikoff [France] ; Alexis Laux [France] ; Amandine Berthet [France] ; Gregory Porras [France] ; Marie-Hélène Canron [France] ; Pedro Barroso-Chinea [France] ; QIN LI [République populaire de Chine] ; CHUAN QIN [République populaire de Chine] ; Marika Nosten-Bertrand [France] ; Bruno Giros [France] ; François Delalande [France] ; Alain Van Dorsselaer [France] ; Anne Vital [France] ; Yannick Goumon [France] ; Erwan Bezard [France, République populaire de Chine] | Endogenous morphine-like compound immunoreactivity increases in parkinsonism |
000359 |
Masahiro Shin [France] ; Caroline Jan [France] ; Carine Jacquard [France] ; Bechir Jarraya [France] ; Jacques Callebert [France] ; Jean-Marie Launay [France] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Stephane Palfi [France] ; Emmanuel Brouillet [France] | Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration |
000369 |
Erwan Bezard [France] ; Serge Przedborski [États-Unis] | A Tale on Animal Models of Parkinson's Disease |
000438 |
Sébastien Paillusson [France] ; Maddalena Tasselli [France] ; Thibaud Lebouvier [France] ; Maxime Michaël Mahe [France] ; Julien Chevalier [France] ; Mandy Biraud [France] ; Chystelle Cario-Toumaniantz [France] ; Michel Neunlist [France] ; Pascal Derkinderen [France] | α-Synuclein expression is induced by depolarization and cyclic AMP in enteric neurons |
000440 |
Fanny Schmiijt [France] ; Gael Le Douaron [France] ; Pierre Champy [France] ; Majid Amar [France] ; Blandine Seon-Meniel [France] ; Rita Raisman-Vozari [France] ; Bruno Figadere [France] | Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons |
000441 |
Julie Deguil [France] ; François Chavant [France] ; Claire Lafay-Chebassier [France] ; Marie-Christine Perault-Pochat [France] ; Bernard Fauconneau [France] ; Stéphanie Pain [France] | Time course of MPTP toxicity on translational control protein expression in mice brain |
000488 |
Stephane Besnard [France] ; Michael Decressac [France] ; Pierre Denise [France] | In-vivo deep brain recordings of intranigral grafted cells in a mouse model of Parkinson's disease |
000517 |
Roberta Cavalcanti-Kwiatkoski [Brésil] ; Rita Raisman-Vozari [France] ; Laure Ginestet [France] ; Elaine Del Bel [Brésil] | Altered expression of neuronal nitric oxide synthase in weaver mutant mice |
000570 |
Serena Santucci [France] ; Nicole Zsiirger [France] ; Joëlle Chabry [France] | β-N-methylamino-L-alanine induced in vivo retinal cell death |
000607 |
Dario Cuomo [France, Italie] ; Giuseppina Martella [Italie] ; Emanuela Barabino [France] ; Paola Platania [Italie] ; Daniela Vita [Italie] ; Graziella Madeo [Italie] ; Chelliah Selvam [France] ; Cyril Goudet [France] ; Nadia Oueslati [France] ; Jean-Philippe Pin [France] ; Francine Acher [France] ; Antonio Pisani [Italie] ; Corinne Beurrier [France] ; Christophe Melon [France] ; Lydia Kerkerian-Le Goff [France] ; Paolo Gubellini [France] | Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum : implications for Parkinson's disease treatment |
000608 |
Elvira De Leonibus [Italie] ; Francesca Manago [Italie] ; Francesco Giordani [Italie] ; Francesco Petrosino [Italie] ; Sebastien Lopez [France] ; Alberto Oliverio [Italie] ; Marianne Amalric [France] ; Andrea Mele [Italie] | Metabotropic Glutamate Receptors 5 Blockade Reverses Spatial Memory Deficits in a Mouse Model of Parkinson's Disease |
000697 |
Jacques Epelbaum [France] | Foxa2, une nouvelle piste neuro-développementale pour le Parkinson |
000718 |
Anthony P. Nicholas [États-Unis] ; Farah D. Lubin [États-Unis] ; Penelope J. Hallett [États-Unis] ; Padmapriya Vattem [États-Unis] ; Paula Ravenscroft [Royaume-Uni] ; Erwan Bezard [France] ; SHAOBO ZHOU [Royaume-Uni] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] ; J. David Sweatt [États-Unis] ; David G. Standaert [États-Unis] | Striatal histone modifications in models of levodopa-induced dyskinesia |
000737 |
Dieter Scheller [Allemagne] ; Christine Stichel-Gunkel [Allemagne] ; Hermann Lübbert [Allemagne] ; Gregory Porras [France] ; Paula Ravenscroft [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Erwan Bezard [France, Royaume-Uni] | Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease |
000745 |
Carine Chassain [France] ; Guy Bielicki [France] ; Elodie Durand [France] ; Stéphane Lolignier [France] ; Fatma Essafi [Tunisie] ; Amidou Traore [France] ; Franck Durif [France] | Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse |
000748 |
Charlotte Laloux [France] ; Philippe Derambure [France] ; Alexandre Kreisler [France] ; Elise Houdayer [France] ; Servane Brueziere [France] ; Régis Bordet [France] ; Alain Destée [France] ; Christelle Monaca [France] | MPTP-treated mice : long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations |
000760 |
Nathalie Thiriet [France] ; Lahouari Amar [France] ; Xauier Toussay [France] ; Virginie Lardeux [France] ; Bruce Ladenheim [États-Unis] ; Kevin G. Becker [États-Unis] ; Jean Lud Cadet [États-Unis] ; Marcello Solinas [France] ; Mohamed Jaber [France] | Environmental enrichment during adolescence regulates gene expression in the striatum of mice |
000777 |
A. Marighetto [France] ; S. Valerio [France] ; J. N. Philippin [France] ; V. Bertaina-Anglade [France] ; C. Drieu La Rochelle [France] ; R. Jaffard [France] ; P. Morain [France] | Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents |
000781 |
Daniel Alvarez-Fischer [Allemagne] ; Carmen Henze [Allemagne] ; Corinna Strenzke [Allemagne] ; Jan Westrich [Allemagne] ; Boris Ferger [Allemagne] ; Günter U. Höglinger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Andreas Hartmann [Allemagne, France] | Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice |
000803 |
| Réunion conjointe de l'AFPB : Italie/Croatie/Grèce/Espagne, Marseille, 3 novembre 2005 |
000843 |
Charlotte Laloux [France] ; Philippe Derambure [France] ; Jean-Marie Jacquesson [France] ; Régis Bordet [France] ; Alain Destée [France] ; Christelle Monaca [France] | The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated mice |
000850 |
Elvira De Leonibus [Italie] ; Tiziana Pascucci [Italie] ; Sebastien Lopez [France] ; Alberto Oliverio [Italie] ; Marianne Amalric [France] ; Andrea Mele [Italie] | Spatial deficits in a mouse model of Parkinson disease |
000851 |
Elvira De Leonibus [Italie] ; Tiziana Pascucci [Italie] ; Sebastien Lopez [France] ; Alberto Oliverio [Italie] ; Marianne Amalric [France] ; Andrea Mele [Italie] | Spatial deficits in a mouse model of Parkinson disease |
000880 |
Alexandre Kreisler [France] ; Patrick Gele [France] ; Jean-Francois Wiart [France] ; Michel Lhermitte [France] ; Alain Destke [France] ; Régis Bordet [France] | Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease : Fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not |
000883 |
Emmanuelle Lagrue [France] ; Sylvie Chalon [France] ; Sylvie Bodard [France] ; Elie Saliba [France] ; Pierre Gressens [France] ; Pierre Castelnau [France] | Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated mice |
000918 |
Fabrice Guillemot [France] ; Italina Cerutti [France] ; Charles Auffray [France] ; Marie-Dominique Devignes [France] | A transgenic mouse model engineered to investigate human brain-derived neurotrophic factor in vivo |
000B00 |
Magali Periquet [France] ; Olga Corti [France] ; Sandrine Jacquier [France] ; Alexis Brice [France] | Proteomic analysis of parkin knockout mice : alterations in energy metabolism, protein handling and synaptic function |
000B14 |
Yan-Qin Shen [République populaire de Chine, France] ; Guillaume Hebert [France] ; Yun Su [France] ; Elizabeth Moze [France] ; Pierre J. Neveu [France] ; Kang-Sheng Li [République populaire de Chine] | In mice, production of plasma IL-1 and IL-6 in response to MPTP is related to behavioral lateralization |
000C18 |
Howard T. J. Mount [Canada] ; Jean-Claude Martel [France] ; Paul Fluit [Canada] ; YINGJI WU [Canada] ; Eleanor Gallo-Hendrikx [Canada] ; Cristina Cosi [France] ; Marc R. Marien [France] | Progressive sensorimotor impairment is not associated with reduced dopamine and high energy phosphate donors in a model of ataxia-telangiectasia |
000C29 |
P. O. Fernagut [France] ; E. Diguet [France] ; B. Bioulac [France] ; F. Tison [France] | MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: eeference to striatonigral degeneration |
000C68 |
Elsa Y. Pioli [France] ; Sandra Dovero [France] ; Bernard H. Bioulac [France] ; Christian E. Gross [France] ; Erwan Bezard [France] | Asymmetrically lesioned mesencephalon in healthy rodents: call for caution |
000D35 |
Guillaume Hebert [France] ; Josette Arsaut [France] ; Robert Dantzer [France] ; Jacques Demotes-Mainard [France] | Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin |
000D51 |
Christian E. Gross [France] ; Paula Ravenscroft [France] ; Sandra Dovero [France] ; Mohamed Jaber [France] ; Bernard Bioulac [France] ; Erwan Bezard [France] | Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice |
000D57 |
Jeffrey N. Joyce [États-Unis] ; Steve Presgraves [États-Unis] ; Lynn Renish [États-Unis] ; Sabinne Borwege [États-Unis] ; Tracy Osredkar [États-Unis] ; Diane Hagner [États-Unis] ; Maria Replogle [États-Unis] ; Mateo Pazsoldan [États-Unis] ; Mark J. Millan [France] | Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole |
000D60 |
Jose-Luis Gonzalez De Aguilar [France] ; Frédérique Rene [France] ; Luc Dupuis [France] ; Jean-Philippe Loeffler [France] | Neuroendocrinology of neurodegenerative diseases: Insights from transgenic mouse models |
000D99 |
Karine Parain [France] ; Céline Hapdey [France] ; Estelle Rousselet [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne C. Hirsch [France] | Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin |
000E09 |
Carine Cleren [France] ; Bertrand Naudin [France] ; Jean Costentin [France] | Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons |
000E89 |
Estelle Rousselet [France] ; Jacques Callebert [France] ; Karine Parain [France] ; Chantal Joubert [France] ; Stéphane Hunot [France] ; Andreas Hartmann [France] ; Claude Jacque [France] ; Fernando Perez-Diaz [France] ; Charles Cohen-Salmon [France] ; Jean-Marie Launay [France] ; Etienne C. Hirsch [France] | Role of TNF-α receptors in mice intoxicated with the parkinsonian toxin MPTP |
000E95 |
T. Breidert [France] ; J. Callebert [France] ; M. T. Heneka [Allemagne] ; G. Landreth [États-Unis] ; J. M. Launay [France] ; E. C. Hirsch [France] | Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease |
000F24 |
Samuel G. Speciale [États-Unis] | MPTP: Insights into parkinsonian neurodegeneration |
000F44 |
Aïcha Douhou [France] ; Thomas Debeir [France] ; Mario Gustavo Murer [Argentine] ; Louis Do [France] ; Noëlle Dufour [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Georg Andrees Bohme [France] ; Yves Agid [France] ; Rita Raisman-Vozari [France] | Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice |
000F51 |
Diego Centonze [Italie] ; Alessandro Usiello [France] ; Paolo Gubellini [Italie] ; Antonio Pisani [Italie] ; Emiliana Borrelli [France] ; Giorgio Bernardi [Italie] ; Paolo Calabresi [Italie] | Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors |
000F62 |
Marion Blin [France] ; Wim E. Crusio [États-Unis] ; Tobias Hevor [France] ; Jean-Francois Cloix [France] | Chronic inhibition of glutamine synthetase is not associated with impairment of learning and memory in mice |
000F73 |
A. Nicotra [Italie] ; S. H. Parvez [France] | Apoptotic molecules and MPTP-induced cell death |
000F82 |
| EFFETS D'UNE DEPOLARISATION CHRONIQUE SUR LE DEVELOPPEMENT ET LA SURVIE DES NEURONES DOPAMINERGIQUES DU MESENCEPHALE : MODULATION PAR DES ANTAGONISTES DE LA TRANSMISSION GLUTAMATERGIQUE |
001043 |
Karine Parain [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne Hirsch [France] | Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice |
001087 |
Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Doubou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Caspase-3 activation in 1 -methyl-4-phenyl- 1, 2,3,6-tetrahydropyridine (MPTP)-treated mice |
001175 |
A. Boireau [France] ; P. Dubedat [France] ; F. Bordier [France] ; A. Imperato [France] ; S. Moussaoui [France] | The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP+ accumulation |
001177 |
M. G. Murer [France, Argentine] ; G. Dziewczapolski [Argentine] ; P. Salin [France] ; M. Vila [France] ; K. Y. Tseng [Argentine] ; M. Ruberg [France] ; M. Rubinstein [Argentine] ; M. A. Kelly [États-Unis] ; D. K. Grandy [États-Unis] ; M. J. Low [États-Unis] ; E. Hirsch [France] ; R. Raisman-Vozari [France] ; O. Gershanik [Argentine] | The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice |
001188 |
M. Grandbois [Canada] ; M. Morissette [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada] | Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice |
001190 |
Patrice Mayer [France] ; Pascale Brunel [France] ; Céline Chaplain [France] ; Christel Piedecoq [France] ; Francis Calmel [France] ; Philippe Schambel [France] ; Philippe Chopin [France] ; Thierry Wurch [France] ; Petrus J. Pauwels [France] ; Marc Marien [France] ; Jean-Louis Vidaluc [France] ; Thierry Imbert [France] | New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with α2-Adrenoceptor antagonist activity |
001242 |
D. C. Rogers [Royaume-Uni] ; B. Costall [Royaume-Uni] ; A. M. Domeney [France] ; P. A. Gerrard [Royaume-Uni] ; M. Greener [Royaume-Uni] ; M. E. Kelly [Royaume-Uni] ; J. J. Hagan [Royaume-Uni] ; A. J. Hunter [Royaume-Uni] | Anxiolytic profile of ropinirole in the rat, mouse and common marmoset |
001315 |
M. Merad-Saïdoune [France] ; E. Boitier [France] ; A. Nicole [France] ; C. Marsac [France] ; J. C. Martinou [Suisse] ; B. Sola [France] ; P.-M. Sinet [France] ; I. Ceballos-Picot [France] | Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents the brain mitochondrial respiratory dysfunction induced by glutathione depletion |
001328 |
C. Fillebeen [France] ; V. Mitchell [France] ; D. Dexter [Royaume-Uni] ; M. Benaissa [France] ; J.-C. Beauvillain [France] ; G. Spik [France] ; A. Pierce [France] | Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment |
001368 |
E. Bezard [France] ; C. E. Gross [France] ; M.-C. Fournier [France] ; S. Dovero [France] ; B. Bloch [France] ; M. Jaber [France] | Absence of MPTP-lnduced neuronal death in mice lacking the dopamine transporter |
001413 |
P. Emond [France] ; L. Farde [Suède] ; S. Chalon [France] ; C. Belzung [France] ; V. Mauclaire [France] ; J. P. Chiron [France] ; C. Halldin [Suède] ; C. Besnard [France] ; D. Guilloteau [France] | Toxicity, mutagenicity, and behavioral effects of β-CIT, a ligand for dopamine transporter exploration by SPECT |
001414 |
E. Bezard [France] ; T. Boraud [France] ; C. Imbert [France] ; S. Dovero [France] ; B. Bioulac [France] ; C. E. Gross [France] | Towards a dynamic approach of experimental parkinsonism |
001428 |
A. Boireau [France] ; M. Meunier [France] ; A. Imperato [France] | Ouabain-induced increase in dopamine release from mouse striatal slices is antagonized by riluzole |
001444 |
W. Krezel [France] ; N. Ghyselinck [France] ; T. A. Samad [France] ; V. Dupe [France] ; P. Kastner [France] ; E. Borrelli [France] ; P. Chambon [France] | Impaired locomotion and dopamine signaling in retinoid receptor mutant mice |
001458 |
A. Nicole [France] ; D. Santiard-Baron [France] ; I. Ceballos-Picot [France] | Direct evidence for glutathione as mediator of apoptosis in neuronal cells : Dossier "Apoptosis Part II" |
001467 |
N. Aubin [France] ; O. Curet [France] ; A. Deffois [France] ; C. Carter [France] | Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice |
001478 |
| Effet de la mutation weaver sur la dégénérescence des neurones dopaminergiques du mésencéphale ventral : analyse de l'expression du transporteur membranaire de la dopamine et d'un canal potassique couplé à une protéine G |
001548 |
A. Boireau [France] ; F. Bordier [France] ; P. Dubedat [France] ; C. Peny [France] ; A. Imperato [France] | Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice |
001568 |
N. B. Mercuri [Italie] ; A. Saiardi [France] ; A. Bonci [Italie] ; R. Picetti [France] ; P. Calabresi [Italie] ; G. Bernardi [Italie] ; E. Borrelli [France] | Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice |
001569 |
E. Bezard [France] ; S. Dovero [France] ; B. Bioulac [France] ; C. E. Gross [France] | Kinetics of nigral degeneration in a chronic model of MPTP-treated mice |
001580 |
L. J. Anghileri [France] ; P. Thouvenot [France] ; A. Bertrand [France] | Effects of iron complexes on brain calcium homeostasis |
001581 |
E. Bezard [France] ; S. Dovero [France] ; B. Bioulac [France] ; C. Gross [France] | Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice |
001595 |
C. Adelbrecht [France] ; M. G. Murer [France] ; I. Lauritzen [France] ; F. Lesage [France] ; M. Ladzunski [France] ; Yves Agid [France] ; R. Raisman-Vozari [France] | An immunocytochemical study of a G-protein-gated inward rectifier K+ channel (GIRK2) in the weaver mouse mesencephalon |
001655 |
C. Adelbrecht [France] ; Yves Agid [France] ; R. Raisman-Vozari [France] | Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area |
001674 |
| Analyse moléculaire et cellulaire de la mutation weaver de la souris |
001713 |
JA-HYUN BAIK [France] ; R. Picetti [France] ; A. Saiardi [France] ; G. Thiriet [France] ; A. Dierich [France] ; A. Depaulis [France] ; M. Le Meur [France] ; E. Borrelli [France] | Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors |
001720 |
A. Boireau [France] ; F. Bordier ; P. Dubedat ; A. Doble | Methamphetamine and dopamine neurotoxicity : differential effects of agents interfering with glutamatergic transmission |
001742 |
B. Naudin [France] ; J.-J. Bonnet ; J. Costentin | Acute L-DOPA pretreatment potentiates 6-hydroxydopamine-induced toxic effects on nigro-striatal dopamine neurons in mice |
001784 |
P. Gaspar [France] ; N. B. Jelloun ; A. Febvret | Sparing of the dopaminergic neurons containing calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice |
001787 |
A. Boireau [France] ; P. Dubedat ; F. Bordier ; C. Peny ; J.-M. Miquet ; G. Durand ; M. Meunier ; A. Doble | Riluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice |
001818 |
| Caractérisation moléculaire de récepteurs dopaminergiques murins de sous-type D2 et de leur mécanisme de transduction du signal |
001859 |
I. Marey-Semper [France] ; M. Gelman ; M. Levi-Strauss | The high sensitivity to rotenone of striatal dopamine uptake suggests the existence of a constitutive metabolic deficiency in dopaminergic neurons from the substantia nigra |
001957 |
L. J. Anghileri [France] | Effects of complexes iron and aluminium on brain calcium |
001A94 |
G. Renoux ; K. Biziere ; M. Renoux ; R. Steinberg ; J.-P. Kan ; J.-M. Guillaumin | Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice |